汉森制药(002412.SZ)：取得换发《药品生产许可证》

Core Viewpoint - Hansen Pharmaceutical (002412.SZ) has received a renewed Drug Production License from the Hunan Provincial Drug Administration, ensuring the company's normal production operations until November 6, 2030, with no significant impact on its performance [1] Group 1 - The renewed Drug Production License is valid until November 6, 2030 [1] - The renewal was prompted by the impending expiration of the original license [1] - The acquisition of the new license guarantees the company's ongoing production and operations [1]